Overall our findings of the universal expression of FPR1 in human GBM tumors, together with previous reports on the contribution of FPR1 to the survival benefit of animals treated with siRNA against FPR1 [9, 20], indicate that this receptor might be a interesting target for novel drug development. Here, FPR1 is linked to glioblastoma.